Salomon & Ludwin’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5K Buy
+904
New +$8.72K ﹤0.01% 1433
2026
Q1
Sell
-998
Closed -$12.1K 2159
2025
Q4
$12.1K Sell
998
-1
-0.1% -$11 ﹤0.01% 1320
2025
Q3
$9.09K Buy
+999
New +$7K ﹤0.01% 1382

Other funds holding NEO

Salomon & Ludwin's NEO Position: Q2 2026 in Review

Salomon & Ludwin opened a new position in NeoGenomics (NEO) in Q2 2026: 904 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: Salomon & Ludwin previously reported a position in NEO as recently as Q4 2025.

Salomon & Ludwin first reported a position in NEO in Q3 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Salomon & Ludwin held 904 shares of NeoGenomics worth $13.5K as of Q2 2026.
  • NeoGenomics was a new Salomon & Ludwin position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1433 holding.
  • Salomon & Ludwin first reported a position in NeoGenomics in Q3 2025 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.